Digitalization of Banks for regulatory and licensing regime for India

Збережено в:

Бібліографічні деталі
Автор:	SHAH,MEET ACHAL
Формат:	Дисертація Книга
Мова:	Англійська
Опубліковано:	Mumbai NMIMS Mumbai 2022
Предмети:	Digitalization of Banks for regulatory and licensing regime
Теги:	Додати тег Немає тегів, Будьте першим, хто поставить тег для цього запису!

Схожі ресурси

BASICS OF LICENSING AND LICENSING AGREEMENT
за авторством: VORA RISHABH
Опубліковано: (1218)

An Analysis on Cross Border Insolvency Regime in India & Abroad.
за авторством: MAHESHWARI, KESHAV
Опубліковано: (2014)

Parallel Importation of Works Protected under the Copyright Regime.
за авторством: SHANGHAVI, AAKANKSHA
Опубліковано: (2014)

Music Licensing and Payment of Royalties in the Digital Music Marketplace
за авторством: Saraswat, Anuja
Опубліковано: (2022)

Legal and Regulatory Aspects of Banking
за авторством: Zacharias, K D; Ravindranath, C P; Kulkarni, P R; Gopalakris
Опубліковано: (2008)

Legal and Regulatory Aspects of Banking
за авторством: Zacharias, K D; Ravindranath, C P; Kulkarni, P R; Gopalakris
Опубліковано: (2008)

Legal and Regulatory Aspects of Banking
за авторством: IIBF
Опубліковано: (2012)

An Analysis Of The Insolvency Regime Governing MSMEs
за авторством: Rao,Ketaki
Опубліковано: (2024)

Global IPR Regime and Broadcasting Rights Implications for India.
за авторством: TULSHIAN, RIDDHI
Опубліковано: (2014)

NBFCs: Regulatory framework in India
за авторством: GUPTA,RHEA MANGAL
Опубліковано: (2022)

"Part I - Regulatory Framework for Coronary Stents in Regulated and Semi- Regulated Countries. Part II - Understanding Regulatory Submissions: Ensuring Global Regulatory Compliance"
за авторством: Tyagi Somya

"Part I - Analysis of Regulatory framework for Nanopharmaceuticals in the US, EU and India. Part II - Regulatory Affairs and Dossier Management at Cipla Ltd"
за авторством: Patel Aiman

"Part I - Regulatory Considerations for Biologics Approval Processes in USA, India and EU Part II - Exploring Regulatory Affairs and Global Submissions "
за авторством: Pawar Srushti

"Part I Regulatory Pathway And Formulation Strategy For 505(B)(2) Filing Of Oral Dispersible Strips In Anti-Epileptic Therapy Part II Navigating the Regulatory Compliance at Glaxosmith Kline Pharmaceuticals Limited for General Medicine Products Concerning Licenses and Best Practices"
за авторством: Nair Keerthi

Part I - Regulatory Framework for Development of Paediatric Formulations Part II - Exploring Regulatory Submissions in Emerging Market
за авторством: Dand Chandni

FDA REGULATORY AFFAIRS
за авторством: MANTUS DAVID
Опубліковано: (2021)

Pharmaceutical Regulatory Process,
за авторством: Berry I.R
Опубліковано: (2025)

Drug Regulatory Affairs
за авторством: Itkar, Sachin
Опубліковано: (2022)

Drug Regulatory Affairs
за авторством: Singh
Опубліковано: (2023)

Drug Regulatory Affairs
за авторством: Gajendra
Опубліковано: (2023)

"Part I Regulatory Policy Framework for Entrepreneurship with Pharmaceutical Avenues Part II Hands-On Experience at Regulatory Affairs Department of Cipla"
за авторством: Vasmatkar Mahesh

Law of Easements and Licenses
за авторством: Narayana, P. S.
Опубліковано: (2020)

Regulation and Regulatory Process in India
за авторством: Kumar, Manoj
Опубліковано: (2019)

Drug Regulatory Affairs (PB)
за авторством: Bigoniya
Опубліковано: (2019)

Part I Real World Evidence for Regulatory Decision Making: Indian Framework Part II Navigating the USFDA Regulatory Landscape: Insights from Theory to Application
за авторством: Gupta Adarsh

"Part I - Regulatory Considerations of Nitrosamines: Exploring Mutagenic and Impurities and Genotoxicity in Pharmaceuticals Part II - Navigating Regulatory Frameworks : A practical Approach To Global Compliance"
за авторством: Gharat Sejal

Automated Document Summarizer for Bank Regulatory Documents
за авторством: Malkar, Raj Narsinha
Опубліковано: (2024)

"Part I Nisin-Silver Nanoconjugate in Polymeric Microneedles for Antimicrobial Action and Regulatory Aspects of Microneedles in India, USA and Europe Part II Navigating USFDA and CDSCO Regulatory Requirements and Hadling the Documentation Approaches"
за авторством: Domb Dnyaneshwari

"Part I Comparison of Regulatory Considerations for Repurposed Drugs in US, EU, & India Part II Optimizing Regulatory Processes Enhancing Product Life Cycle Management from Initial Filimg to Post-Approval"
за авторством: Bajaj Aanchal

"Part I - Regulatory Framework and Market Dynamics of Nutraceuticals in Major International Markets Part II - Developing Dossier and Regulatory Submission Strategies for Pharmaceutical Market Authorization in the European Union."
за авторством: Bose Anushree

"Part I - Regulatory Perspective and Strategies to Strength and Speed Ip Commercialization Process Part II - Dossier Preparation and Regulatory Compilance in ROW: A Pratical Approach in Ajanta Pharma"
за авторством: Dwivedi Priyam

"A Textbook of Pharmaceutical Regulatory Science"
за авторством: Mrs. Mitesh P. Sonawane
Опубліковано: (2022)

Unravelling The Challenges Encountered In The Cross-Border Merger Regime-A Comprehensive Analysis
за авторством: Talekar,Vaishnavi
Опубліковано: (2024)

"Part I - Regulatory Framework and Innovations using 505(b)(2) Pathway in Drug Development and Approval Part II - Internship at Bliss GVS Pharma in Regulatory Affairs Department- US Market"
за авторством: Patel Astha

"Part I - Eurasian Economic Union: Analyzing Drug Registration Pathways, Dossier Requirements and Comparison with European Union's Regulatory Frameworks Part II - Implementation of Regulatory Practices for Pharmaceutical Submission in the European Union"
за авторством: CP Keerthana

"Part I - Regulatory Compliance Leveraging Artificial Intelligence - A comprehensive Study of Opportunities and Challenges Part II - From Analytical Profiling to Regulatory Affairs - Stability, Assessment, Forced Degradation and RA Submissions for Emerging Markets "
за авторством: Mulla Sahil

"Part I - Regulatory Aspects for Zygomatic Implants as Medical Devices in India Part II - Internship at Meril Life Sciences Pvt. Ltd & IPCA Laboratories Ltd"
за авторством: Mistry Yukta

"Part I Regulatory Analysis and Comparison of Medical Device Recall In India, US and Europe: Understanding Causes and Consequences. Part II Dossier Preparation and Submission for US Market in Sun Pharmaceutical Industries"
за авторством: Bodke Samruddhi

Part I Regulatory Considerations and Comparison of Drug Product Recall For Nitrosamine Impurity In India, USA And Europe Part II Navigating Regulatory Framework: A Strategic Approach in Industry"
за авторством: Mutalik Rucha

"Part I Exploring The Regulatory Dynamics Of Artificial Intelligence (AI) and Machine Learning(ML) Based Smart Devices Part II Navigating Though the Reglatory Compliances at Glaxosmithkline Pharmaceuticals Limited for Clinical Trials in India"
за авторством: Mourya Aman